EP 1257565 A1 20021120 - MUCIN-1 DERIVED ANTIGENS AND THEIR USE IN IMMUNOTHERAPY
Title (en)
MUCIN-1 DERIVED ANTIGENS AND THEIR USE IN IMMUNOTHERAPY
Title (de)
VON MUCIN-1 ABGELEITETE ANTIGENE UND IHRE VERWENDUNG IN DER IMMUNTHERAPIE
Title (fr)
ANTIGENES DERIVES DE MUCINE-1 ET LEUR UTILISATION EN IMMUNOTHERAPIE
Publication
Application
Priority
- AU 0100090 W 20010201
- AU PQ536900 A 20000201
- US 59387000 A 20000614
Abstract (en)
[origin: WO0157068A1] Peptides and polypeptides capable of eliciting the immune response are disclosed which comprise an amino acid sequence substantially corresponding to that of an epitope of the non-VNTR, non-leader region of mucin. The peptides or polypeptides are useful themselves, or in the form of fusion proteins or conjugate compounds with carbohydrate polymers, in the prevention or treatment of disease states, particularly carcinomas such as adenocarcinomas. DNA vaccines and uses of the peptides and polypeptides for pulsing dentritic cells for <i>in vivo</i> transfer are also disclosed.
IPC 1-7
C07K 7/06; C07K 7/08; C07K 14/82; C07K 16/32; A61K 38/08; A61K 39/395; A61K 39/44; A61P 35/00
IPC 8 full level
C12N 15/09 (2006.01); A61K 31/711 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); C07K 14/435 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01); C07K 19/00 (2006.01)
CPC (source: EP)
A61P 35/00 (2018.01); A61P 37/04 (2018.01); C07K 14/4727 (2013.01); A61K 38/00 (2013.01); A61K 39/00 (2013.01); A61K 2039/53 (2013.01); C07K 2319/00 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0157068 A1 20010809; CA 2399026 A1 20010809; EP 1257565 A1 20021120; EP 1257565 A4 20050406; JP 2003533181 A 20031111
DOCDB simple family (application)
AU 0100090 W 20010201; CA 2399026 A 20010201; EP 01902160 A 20010201; JP 2001557899 A 20010201